{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-157328","form_type":"8-K","ticker":"ALDX","cik":"0001341235","company_name":"Aldeyra Therapeutics, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.021860+00:00","generated_at":"2026-06-01T05:30:14.538963+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aldeyra annual meeting results: directors elected, auditor ratified, say-on-pay approved","bullets":["Directors Nancy B. Miller-Rich (21.9M for, 12.6M withheld) and Ben R. Bronstein (22.7M for, 11.8M withheld) elected as Class I directors.","Shareholders ratified BDO USA as independent auditor for FY 2024: 44.1M for, 372.8K against, 186.6K abstain.","Non-binding advisory vote on named executive officer compensation approved: 31.5M for, 2.9M against, 126.6K abstain, 10.2M broker non-votes.","Total shares voted: 44,659,863 of 59,414,489 eligible (75.2% quorum)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-157328","json":"https://secwatch.observer/filing/0001193125-24-157328.json","markdown":"https://secwatch.observer/filing/0001193125-24-157328.md","text":"https://secwatch.observer/filing/0001193125-24-157328.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1341235/000119312524157328/0001193125-24-157328-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1341235/000119312524157328/d843373d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:30:14.538963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}